Inhibikase Therapeutics, Inc.IKTNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Over Time
Trending higher, above historical average.
Left:
||||
Revenue minus cost of goods sold
Latest
$-26272.00
↑ 99% above average
Average (8y)
$-2.48M
Historical baseline
Range
High:$393847.00
Low:$-13.36M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-26272.00 | +99.8% |
| 2023 | $-13.36M | -11544.6% |
| 2022 | $116717.00 | +101.4% |
| 2021 | $-8.26M | -4127.9% |
| 2020 | $-195334.00 | +86.3% |
| 2019 | $-1.43M | -463.1% |
| 2018 | $393847.00 | +29.0% |
| 2017 | $305245.00 | +152.3% |
| 2016 | $121000.00 | - |